Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles

Journal of Biotechnology

Volumn 155, Issue 3, 2011, Pages 287-292

  Kim, Jae Hong ^a   Yeom, Ji Hyun ^b   Ko, Jeong Jae ^a   Han, Min Su ^b   Lee, Kangseok ^b   Na, Soon Young ^a   Bae, Jeehyeon ^a  

^a CHA University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Anti microRNA oligonucleotides (AMOs); Gold nanoparticles; MCL 1; MiR 29

Indexed keywords

ANTI-MICRORNA OLIGONUCLEOTIDES (AMOS); ANTISENSE; BIOLOGICAL PROCESS; CELL LINES; CELL SURVIVAL; CELL TYPES; DNA OLIGONUCLEOTIDES; FUNCTIONALIZED; GOLD NANOPARTICLE; GOLD NANOPARTICLES; HELA CELL; MCL-1; MICRORNAS; MIR-29; MRNA LEVEL; MYELOID CELLS; THERAPEUTIC TARGETS; TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGANDS;

CELL CULTURE; CELL DEATH; GOLD; NANOPARTICLES; OLIGONUCLEOTIDES;

DNA;

COMPLEMENTARY DNA; DNA; GOLD NANOPARTICLE; MESSENGER RNA; MICRORNA; MICRORNA 21; MIR 29B; MIRNA OLIGONUCLEOTIDE ANTIBODY; NANOCOATING; OLIGONUCLEOTIDE; PROTEIN MCL 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; GENE DELIVERY SYSTEM; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; GOLD; HELA CELLS; HUMANS; METAL NANOPARTICLES; MICRORNAS; MOLECULAR SEQUENCE DATA; NANOCONJUGATES; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA-BINDING PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 81155159801     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2011.07.014     Document Type: Article

References (38)

1. Andree H.A., Reutelingsperger C.P., Hauptmann R., Hemker C., Hermens W.T., Willems G.M. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J. Biol. Chem. 1990, 265:4923-4928.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 2005, 37:766-770.
4. Chithrani B.D., Chan W.C. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7:1542-1550.
5. Clohessy J., Zhuang J., de Boer J., Gil-Gómez G., Brady H. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J. Biol. Chem. 2006, 281:5750-5759.
6. Conwell C.C., Huang L. Non-viral gene delivery: stretching is the point. Gene Ther. 2006, 13:377-378.
7. Daniel M.-C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004, 104:293-346.
8. Davis S., Lollo B., Freier S., Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 2006, 34:2294-2304.
9. Esau C.C. Inhibition of microRNA with antisense oligonucleotides. Methods 2008, 44:55-60.
10. Garzon R., Heaphy C.E.A., Havelange V., Fabbri M., Volinia S., Tsao T., Zanesi N., Kornblau S.M., Marcucci G., Calin G.A., Andreeff M., Croce C.M. MicroRNA 29b functions in acute myeloid leukemia. Blood 2009, 114:5331-5341.
11. Giljohann D.A., Patel P.C.S.D., Millstone J.E., Rosi N.L., Mirkin C.A. Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett. 2007, 7:3818-3821.
12. Han J., Goldstein L., Gastman B., Rabinowich H. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J. Biol. Chem. 2006, 281:10153-10163.
13. Jang J., Lee T., Yang E., Min D., Kim Y., Kim S., Choi Y., Park J., Choi K., Kwon T. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1. Exp. Cell Res. 2010, 316:2194-2203.
14. Juliano R., Alam M.R., Dixit V., Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res. 2008, 36:4158-4171.
15. Kaufmann S., Karp J., Svingen P., Krajewski S., Burke P.J., Gore S., Reed J. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood 1998, 91:991-1000.
16. Kim J.-H., Jang H.H., Ryou S.-M., Kim S., Bae J., Lee K., Han M.S. A functionalized gold nanoparticles-assisted universal carrier for antisense DNA. Chem. Commun. 2010, 46:4151-4153.
17. Kim D.W., Park M., Yeom J.H., Go H., Kim S., Han M.S., Lee K., Bae J. Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugated with gold nanoparticles. Biomaterials 2011, 32:2593-2603.
18. Kim S., Ricci M., El-Deiry W. Mcl-1: a gateway to TRAIL sensitization. Cancer Res. 2008, 68:2062-2064.
19. Kozopas K., Yang T., Buchn H., Zhou P., Craig R. MCL-1 a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL1. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:3516-3520.
20. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
21. Melo S.A., Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2010, 1-13.
22. Mott J.L., Kobayashi S., Bronk S.F., Gores G.J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140.
23. Nativo P.I., Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2008, 2:1639-1644.
24. Pan W.-H., Clawson G.A. Antisense applications for biological control. J. Cell. Biochem. 2006, 98:14-35.
25. Raper S.E., Chirmule N., Lee F.S., Wivel N.A., Bagg A., Gao G.-p., Wilson J.M., Batshaw M.L. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenovirural gene transfer. Mol. Genet. Metab. 2003, 80:148-158.
26. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K.R., Han M.S., Mirkin C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312:1027-1030.
27. Ryou S.-M., Kim S., Jang H.H., Kim J.-H., Yeom J.-H., Eom M.S., Bae J., Han M.S., Lee K. Delivery of shRNA using gold nanoparticle-DNA oligonucleotide conjugates as a universal carrier. Biochem. Biophys. Res. Commun. 2010, 398:542-546.
28. Shukla R.B.V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644-10654.
29. Singh Y., Murat P., Defrancq E. Recent developments in oligonucleotide conjugation. Chem. Soc. Rev. 2010, 39:2054-2070.
30. Sprick M.R., Rieser W.M., Rauch C.T.E., Juo P., Blenis J., Krammer P.H., Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000, 12:599-609.
31. Storhoff J.J., Elghanian R., Mucie R.C., Mirkin C.A., Letsinger R.L. One-pot Colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticles probes. J. Am. Chem. Soc. 1998, 120:1959-1964.
32. Taniai M., Grambihler A., Higuchi H., Werneburg N., Bronk S., Farrugia D., Kaufmann S., Gores G. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res. 2004, 64:3517-3524.
33. Thomas L., Lam C., Edwards S. Mcl-1; the molecular regulation of protein function. FEBS Lett. 2010, 584:2981-2989.
34. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., Chin W., Jones J., Woodward A., Le T., Smith C., Smolak P., Goodwin R.G., Rauch C.T., Schuh D.H., Lynch J.C. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 1999, 5:157-163.
35. Xiong Y., Fang J.-H., Yun J.-P., Yang J., Zhang Y., Jia W.-H., Zhuang S.-M. Effects of MicroRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010, 51:836-845.
36. Xu L., Anchordoquy T. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J. Pharm. Sci. 2011, 100:38-52.
37. Yang J., Hung C., Fu C., Lee J., Huang C., Yang M., Lin C., Kao J., Way T. Hispidulin sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by AMPK activation leading to Mcl-1 block in translation. J. Agric. Food Chem. 2010, 58:10020-10026.
38. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.